SONIMEDI Bio Cell Fusion Science Institute is a highly specialized research organization focused on advanced bio-materials and the commercialization of cell-based technologies. Our work centers on the fusion of applied cellular science with next-generation cosmetic innovation. In 2016, we developed Embryonism™, derived from egg embryonic cells—recognized as the world’s first ingredient of its kind to be officially listed in the INCI (International Nomenclature of Cosmetic Ingredients).This breakthrough positioned SONIMEDI as a global pioneer in the industrialization of regenerative bio-materials for skin. Building upon this core technology, the institute continues to advance applications in Slowe Aging and Reverse Aging, delivering high-performance functional ingredients with proven regenerative efficacy to the global skincare market.

With a philosophy grounded in “science that focuses on functional essence,” the SONIMEDI Bio Cell Fusion Science Institute is setting new standards in next-generation dermatological R&D—offering innovation that goes beyond expectations.